Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
Phase of Trial: Phase III
Latest Information Update: 13 Mar 2018
At a glance
- Drugs Tasimelteon (Primary)
- Indications Circadian rhythm sleep disorders
- Focus Therapeutic Use
- Acronyms JET8
- Sponsors Vanda Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 05 Mar 2018 Primary endpoint (Improvement of sleep time during the first night of a phase advance) has been met, according to a Vanda Pharmaceuticals media release.
- 05 Mar 2018 Results presented in a Vanda Pharmaceuticals media release.